January 2022 - Volume 45 - Issue 1 - Contributor Index

Alphabetical Search
A
I
J
V
Author:
Berry, Ella C.

Eosinophilic Vasculitis and Arteritic Anterior Ischemic Optic Neuropathy Associated With Anti-PD-L1 Therapy

Berry, Ella C.; Mullany, Sean; Quinlivan, Alannah; More

Journal of Immunotherapy. 45(1):51-55, January 2022.

Author:
Chen, Xiang
Author:
Cho, Yong Jin
Author:
Craig, Amelia

Eosinophilic Vasculitis and Arteritic Anterior Ischemic Optic Neuropathy Associated With Anti-PD-L1 Therapy

Berry, Ella C.; Mullany, Sean; Quinlivan, Alannah; More

Journal of Immunotherapy. 45(1):51-55, January 2022.

Author:
Craig, Jamie E.

Eosinophilic Vasculitis and Arteritic Anterior Ischemic Optic Neuropathy Associated With Anti-PD-L1 Therapy

Berry, Ella C.; Mullany, Sean; Quinlivan, Alannah; More

Journal of Immunotherapy. 45(1):51-55, January 2022.

Author:
Cui, Jiazhen
Author:
Deng, Guangtong

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Author:
Frank, Angela

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Author:
Hench, Juergen
Author:
Hong, Ruimin
Author:
Hosen, Naoki

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Author:
Hu, Yongxian
Author:
Huang, He
Author:
Kanegae, Mizuki

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Author:
Kim, Bora
Author:
Kimura, Tadashi

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Author:
Klebe, Sonja

Eosinophilic Vasculitis and Arteritic Anterior Ischemic Optic Neuropathy Associated With Anti-PD-L1 Therapy

Berry, Ella C.; Mullany, Sean; Quinlivan, Alannah; More

Journal of Immunotherapy. 45(1):51-55, January 2022.

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Author:
Li, Yayun
Author:
Lim, Wonbong
Author:
Meng, Yu
Author:
Moch, Holger

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Author:
Morita, Satoshi

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Author:
Mullany, Sean

Eosinophilic Vasculitis and Arteritic Anterior Ischemic Optic Neuropathy Associated With Anti-PD-L1 Therapy

Berry, Ella C.; Mullany, Sean; Quinlivan, Alannah; More

Journal of Immunotherapy. 45(1):51-55, January 2022.

Author:
Nakae, Yoshiki

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Author:
Nakata, Jun

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Eosinophilic Vasculitis and Arteritic Anterior Ischemic Optic Neuropathy Associated With Anti-PD-L1 Therapy

Berry, Ella C.; Mullany, Sean; Quinlivan, Alannah; More

Journal of Immunotherapy. 45(1):51-55, January 2022.

Author:
Nienhold, Ronny

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Author:
Nowak, Marta
Author:
Ohno, Satoshi

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Author:
Oji, Yusuke

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Author:
Oka, Yoshihiro

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Author:
Oo, Thein H.
Author:
Park, Mineon

Eosinophilic Vasculitis and Arteritic Anterior Ischemic Optic Neuropathy Associated With Anti-PD-L1 Therapy

Berry, Ella C.; Mullany, Sean; Quinlivan, Alannah; More

Journal of Immunotherapy. 45(1):51-55, January 2022.

Author:
Sachs, Melanie

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Author:
Shouq, Alzaaqi

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Author:
Siggs, Owen M.

Eosinophilic Vasculitis and Arteritic Anterior Ischemic Optic Neuropathy Associated With Anti-PD-L1 Therapy

Berry, Ella C.; Mullany, Sean; Quinlivan, Alannah; More

Journal of Immunotherapy. 45(1):51-55, January 2022.

Author:
Slattery, James

Eosinophilic Vasculitis and Arteritic Anterior Ischemic Optic Neuropathy Associated With Anti-PD-L1 Therapy

Berry, Ella C.; Mullany, Sean; Quinlivan, Alannah; More

Journal of Immunotherapy. 45(1):51-55, January 2022.

Author:
Sugiyama, Haruo

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Eosinophilic Vasculitis and Arteritic Anterior Ischemic Optic Neuropathy Associated With Anti-PD-L1 Therapy

Berry, Ella C.; Mullany, Sean; Quinlivan, Alannah; More

Journal of Immunotherapy. 45(1):51-55, January 2022.

Author:
Sun, Huiyan
Author:
Teng, Xinyi
Author:
Tsuboi, Akihiro

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Author:
Ueda, Yutaka

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Author:
Wang, Yiyun

Eosinophilic Vasculitis and Arteritic Anterior Ischemic Optic Neuropathy Associated With Anti-PD-L1 Therapy

Berry, Ella C.; Mullany, Sean; Quinlivan, Alannah; More

Journal of Immunotherapy. 45(1):51-55, January 2022.

Author:
Xu, Huijun
Author:
Yang, Li
Author:
Ye, Lin

Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

Nishida, Sumiyuki; Morimoto, Soyoko; Oji, Yusuke; More

Journal of Immunotherapy. 45(1):56-66, January 2022.

Author:
Zeng, Furong
Author:
Zhang, Mingming
Author:
Zhao, Houli
Author:
Zu, Cheng
Show: